kaposis sarcomaassociated herpesvirus kshv ninth known human herpesvirus formal name according international committee taxonomy viruses ictv human gammaherpesvirus like herpesviruses informal names used interchangeably formal ictv name virus causes kaposis sarcoma cancer commonly occurring aids well primary effusion multicentric castlemans disease kshv inflammatory cytokine one seven currently known human cancer viruses even many years since discovery known cure kshv associated tumorigenesis moritz kaposi described blood vessel originally called idiopathic multiple pigmented sarcoma skin since eponymously named kaposis sarcoma ks ks first thought uncommon tumor jewish mediterranean populations later determined extremely common throughout subsaharan african populations led first suggestions tumor might caused virus onset aids epidemic early sudden resurgence ks affecting aids patients reported aids patients extraordinary rate cancer careful analysis epidemiologic data valerie beral thomas peterman harold led investigators propose ks caused unknown sexually transmitted virus rarely causes tumors unless host becomes immunosuppressed aidscitation needed early scientists reported seeing herpesviruslike structures ks tumors examined electron microscopy scientists searching agent causing ks agents proposed possible cause including cytomegalovirus hiv pathogen ultimately identified yuan chang patrick moore wife husband team columbia university isolation dna fragments herpesvirus found ks tumor aids chang moore used representational difference analysis rda find kshv comparing ks tumor tissue aids patient unaffected tissue idea behind experiment virus causes ks genomic dna two samples precisely identical except dna belonging virus initial rda experiment isolated two small dna fragments represented less actual viral genome fragments similar still distinct known herpevirus sequences indicating presence new virus starting fragments research team able sequence entire genome virus less two years latercitation needed discovery herpesvirus sparked considerable controversy scientific infighting sufficient data collected show indeed kshv causative agent kaposis virus known widespread infection people living subsaharan africa intermediate levels infection occur mediterranean populations including lebanon saudi arabia italy greece low levels infection occur northern european north american populations gay bisexual men susceptible infection still unknown routes sexual transmission whereas virus transmitted nonsexual routes developing countriescitation needed kshv herpesvirus large doublestranded dna virus protein covering packages nucleic acids called capsid surrounded amorphous protein layer called tegument finally enclosed lipid envelope derived part cell membrane kshv genome approximately nucleic acid bases length viral genome consists kilobaselong unique region encoding expressed viral genes flanked kilobases terminal repeat terminal repeat unit bp length gc content oriented repetitive headtotail fashion kshv rhadinovirus herpes genus remarkable since stolen numerous genes host cells including case kshv genes encode complementbinding protein cyclind g proteincoupled receptor interferon regulatory factor flice inhibitory protein flip well dna synthesis proteins including dihydrofolate reductase thymidine kinase thymidylate synthetase dna polymerase many others human tumor virus possesses genes tumor viruses target cellular pathways illustrating basic level tumor viruses appear attack cellular control pathways socalled tumor suppressor pathwayscitation needed crucial entry kshv cells eph receptor integrins whose identity yet infection virus enters lymphocytes via macropinosomescitation needed virus newly infects cell lipid membrane shed virion travels nucleus viral genome released circularizes episome poorly understood process appears involve homologous recombination terminal repeatscitation needed viral episome chromatinized upon entry host cell entry virus typically remains latent quiet state subset genes encoded kshv latency associated region klar expressed latency including latencyassociated nuclear antigen lana vflip vcyclin micrornas latency hallmark kshvassociated etiologies known date including kshvassociated oncogenesis shown protein coding genes lana noncoding genes micrornas encoded klar important kshv associated tumorigenesis study functions micrornas detailed protocol bacmid mutagenesis complete set celllines carrying microrna deletion mutants established available resource additionally shown vflip vcyclin interfere tgfÎ² signaling pathway indirectly inducing oncogenic host observations represents novel mechanism may important kshv tumorigenesis angiogenesis hallmark kscitation needed latency lana viral protein required viral replication carried host replication machinery lana tethers viral dna cellular chromosomes inhibits retinoblastoma protein suppresses viral genes needed full virus production assembly lytic replication subset virus genes expressed latency fully understood shown latency associated gene expression explained part characteristic epigenetic state kshv episome acquires latency lana plays important role latency regulating host virus transcripts binding multiple active promoters also associates host protein creates marks various signals inflammation may provoke virus enter lytic replication primary viral protein responsible switch latent lytic replication known replication transactivation activator rta cell signaling conditions activate generation rta turn activates synthesis stereotypic cascade secondary tertiary viral proteins ultimately make components virus capsid also dna synthesis enzymes required replicate virus lytic replication believed virus genome replicated continuous linear molecule episome socalled rolling circle model unit genome replicated cut within terminal repeat region packaged virus particle virion virus becomes enveloped lipid membrane transits nucleus cytoplasm exit cell thus whereas kshv genome circular nucleus latently infected cells packaged infectious viruses linear molecule virus enters lytic replication thousands virus particles made single cell usually results death infected cellcitation needed discovered infection virus virus causes may induce lytic reactivation kshv human body causing herpes virus cease latency begin formation cancerous cells discovered medications used treat infection namely nafamostat azithromycin ended promoting production mature virions potentially inducing kshv lytic mechanisms virus contracted well understood healthy individuals infected virus show signs symptoms due immune systems ability keep infection check infection particular concern immunocompromised cancer patients receiving chemotherapy aids patients organ transplant patients high risk showing signs infectioncitation needed recent advances sequencing technologies uncovered virus chromatinized latency also shown virus encoded microrna manipulates interacts host mrna also deregulate host long noncoding rna recently circularrnas circrnas recently discovered ebv kshv infection virus thought lifelong healthy immune system keep virus check many people infected kshv never show symptoms kaposis sarcoma occurs someone infected kshv becomes immunocompromised due aids medical treatment rarely aging kshv known causative agent four global prevalence rate seroprevalence varies significantly geographically infection rates northern european southeast asian caribbean countries mediterranean countries approximately subsaharan african countries approximately south america infection rates low general high among even within individual countries significant variation observed across different regions infection rates xinjiang compared hubei although seroprevalence consistently shown increase age linear countries high infection rates may see higher seroprevalence younger age educational level shown inverse correlation infection individuals infected genital warts generally likely coinfected countries low seroprevalence primarily limited aids ks countries high seroprevalence infection frequent indicating likely mothertochild transmission zambian survey children ks mothers positive whereas children whose mothers ks another zambian survey children seropositive age seroprevalence shown vary significantly gender marital recent common ancestor virus mediterranean iran xinjiang china estimated evolved years highest probability density years recent common ancestor viruses isolated xinjiang years highest probability density years ago given historical links mediterranean xinjiang roman period seems likely virus introduced xinjiang along silk road mutation rate estimated substitutions per site per year highest probability density however global distribution different genotypes kshv potential transmission path need studiescitation needed typing isolates based variable membrane protein six types recognised since persons infected kshv asymptomatically give virus caution used sex partners unprotected sex activities saliva might shared sexual activity prudent advice use condoms needed avoid deep kissing partners kshv hiv infections whose status unknown kaposis sarcoma usually localized tumor treated either surgically local irradiation chemotherapy drugs liposomal anthracyclines paclitaxel may used particularly invasive disease antiviral drugs ganciclovir target replication herpesviruses kshv used successfully prevent development kaposis although tumor develops drugs little use patients aidsks effective therapy highly active antiretroviral therapy reduce hiv aids patients receiving adequate antihiv treatment may reduction kaposis sarcoma occurrence although kshv affects host immune system ample chance clinical intervention recover change one challenge overexpression inhibitory target cell repress immune longtime inflammation stimulation target cell becomes unable respond leads exhausted phenotype activation immunotherapies revive enhance immune cell function comparing immunotherapies therapies targeting antiprogrammed cell death protein deathligand great success kshv infection monocytes increase expression inhibitory molecule cause immune escape many tumor types high expression nk cells kshiv patients cause exhausted phenotype antibody nivolumab pembrolizumab demonstrated significant antitumor effect nivolumab currently ongoing phase clinical trial pembrolizumab shown function treatment hiv ks patients phase phase ii trial treatment thalidomide analog medicine pomalidomide also granted fda pomalidomide shown recover expression help cell display intracellular proteins cytotoxic cells also repress expression increase cell kshv encodes genes multiple noncoding rnas orf genes named based genome position homologous genes first rhadinovirus described herpesvirus saimiri k genes unique kshv kshv genes wellcharacterized functions others remain uncharacterizedcitation needed dihydrofolate reductase gb envelope glycoprotein involved viral entry dna polymerase required viral dna replication regulates rna export responses type ifns viral transcription factors required expression late genes vtk thymidine kinase gh envelope glycoprotein involved viral entry uncharacterized capsid proteins involved viral particle formation unclear function unclear function mutant express early viral genes vpk viral protein kinase multiple roles replication cycle sox dual function protein dnase activity required genome packaging rnase activity regulates host gene expression involved viral particle formation gm envelope glycoprotein helicase primase dna replication uncharacterized tegument protein binds prevents dephosphorylation ribosomal kinases rsks erk modulate erkrsk mapk signaling pathway gl envelope glycoprotein involved viral entry may required viral gene expression rta replication transcription activator major transcription factor driving lytic kshv reactivation kicgas tegument protein required formation virions inhibition cgas dna sensing gn envelope glycoprotein uncharacterized mta regulates rna stability export translation viral genes polymerase processivity factor accessory subunit viral dna polymerase nuclear egress thymidylate synthase vcyclin lana latencyassociated nuclear tethers genome chromosome latency also regulates host gene expression cytoplasmic form lana may inhibit activation immune responses vgpcr fgarat pan polyadenylated nuclear rna linear circular rnas mirnas mirks viral micrornas expressed latency regulate proliferation cell death involved oncogenesis interleukin homolog ubiquitin ligases regulates antigen presentation chemokine chemokine transcriptional repressor modulates chromatin envelope glycoprotein viral interferon regulatory factor circular rna circrna also generated locus initially designated expressed latency pel cell lines also bona fide lytic factor like kaposin vflip